Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL28845398 | 0.88 | ALDH1A1 (0.61) | ALDH1A1TSHRTDP1 | |
| SCHEMBL15156484 | 0.88 | ALDH1A1 (0.61) | ALDH1A1TSHRTDP1 | |
| Chloromethane SCHEMBL774036 | 0.87 | — | — | |
| SCHEMBL503396 | 0.82 | — | — | |
| SCHEMBL6223 | 0.82 | — | — | |
| SCHEMBL8679785 | 0.82 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1 | |
| Water SCHEMBL10335432 | 0.77 | — | — | |
| SCHEMBL3662439 | 0.77 | — | — | |
| SCHEMBL3664027 | 0.77 | — | — | |
| SCHEMBL3366971 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10899744-B2 | Crystalline form of compound suppressing protein kinase activity, and application thereof | XCOVERY HOLDINGS, INC. (US) | 2021-01-26 | — | — | US | claimed |
| US-20190135792-A1 | CRYSTALLINE FORM OF COMPOUND SUPPRESSING PROTEIN KINASE ACTIVITY, AND APPLICATION THEREOF | XCOVERY HOLDINGS, INC. | 2019-05-09 | — | — | US | claimed |
| EP-3470410-A1 | CRYSTALLINE FORM OF COMPOUND SUPPRESSING PROTEIN KINASE ACTIVITY, AND APPLICATION THEREOF | XCOVERY Holding Company, LLC (CN) | 2019-04-17 | — | — | EP | claimed |
| WO-2008117282-A1 | POLYMORPH OF GRANISETRON BASE AND PRODUCTION PROCESS THEREFOR | CHEMAGIS LTD. (IL) | 2008-10-02 | — | — | WO | claimed |
| US-20080242696-A1 | CRYSTALLINE GRANISETRON BASE AND PRODUCTION PROCESS THEREFOR | CHEMAGIS LTD. (IL) | 2008-10-02 | — | — | US | claimed |
| EP-4400498-A1 | AMORPHOUS SUBSTANCES, CRYSTALS, PHARMACEUTICAL COMPOSITIONS, PREPARATION METHODS AND USES OF THIOHYDANTOIN COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Suzhou Kintor Pharmaceuticals, Inc. (CN) | 2024-07-17 | — | — | EP | disclosed |
| US-20240182442-A1 | ANHYDROUS POLYMORPHS OF ANDROGEN RECEPTOR ANTAGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) | 2024-06-06 | — | — | US | disclosed |
| CN-117736176-A | Pharmaceutically acceptable salts of androgen receptor antagonists and polymorphs thereof, methods of preparation and use | 苏州开拓药业股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| EP-4317136-A1 | ANHYDROUS POLYMORPHS OF ANDROGEN RECEPTOR ANTAGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | Suzhou Kintor Pharmaceuticals, Inc. (CN) | 2024-02-07 | — | — | EP | disclosed |
| CN-117043142-A | Anhydrous polymorphs of androgen receptor antagonists, methods of making and uses thereof | 苏州开拓药业股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-116284089-A | Fluoboric part cyanine fluorescent probe and preparation method and application thereof | 四川大学华西医院 | 2023-06-23 | — | — | CN | disclosed |
| CN-109789146-B | Chemokine receptor modulators and uses thereof | 拉普特医疗公司 | 2023-04-18 | — | — | CN | disclosed |
| EP-0880540-B1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | AVENTIS PHARMA INC (US) | 2002-06-12 | — | — | EP | disclosed |
| US-6365597-B1 | FOR THERAPY OF ANDROGEN AND ESTROGEN MEDIATED DISORDERS, INCLUDING BENIGN PROSTATIC HYPERPLASIA, ANDROGEN MEDIATED PROSTATE CANCER, ESTROGEN MEDIATED BREAST CANCER AND ACNE | AVENTIS PHARMACEUTICALS INC. | 2002-04-02 | — | — | US | disclosed |
| US-5866589-A | Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds | PHARMACIA & UPJOHN COMPANY (US) | 1999-02-02 | — | — | US | disclosed |
| US-5693663-A | PESTICIDES; HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-02 | — | — | US | disclosed |
| EP-0797576-A1 | ALKYL SUBSTITUTED PIPERADINYL AND PIPERAZINYL ANTI-AIDS COMPOUNDS | PHARMACIA & UPJOHN COMPANY (US) | 1997-10-01 | — | — | EP | disclosed |
| US-5585384-A | 1-OXY-FUNCTIONAL GROUP-2-ALKYLARYL-3-OXO-PYRROLIZINES; INSECTICIDES; NEMATOCIDES; HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1996-12-17 | — | — | US | disclosed |
| WO-1996018628-A1 | ALKYL SUBSTITUTED PIPERADINYL AND PIPERAZINYL ANTI-AIDS COMPOUNDS | PHARMACIA & UPJOHN COMPANY (US) | 1996-06-20 | — | — | WO | disclosed |
| US-5288874-A | Insecticides, miticides | BAYER AKTIENGESELLSCHAFT (DE) | 1994-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242696-A1 | CRYSTALLINE GRANISETRON BASE AND PRODUCTION PROCESS THEREFOR | GCG, CRH, GCGR | ALDH1A1 4484/4885TSHR 1240/4885TDP1 762/4885 |
| US-10899744-B2 | Crystalline form of compound suppressing protein kinase activity, and application thereof | MAPKAPK5, MAP3K6, MAP3K5 | ALDH1A1 4112/4885TSHR 2309/4885TDP1 2260/4885 |
| US-20240182442-A1 | ANHYDROUS POLYMORPHS OF ANDROGEN RECEPTOR ANTAGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | AR, NR5A1, CYP19A1 | ALDH1A1 392/4885TSHR 1913/4885TDP1 3647/4885 |
| US-20190135792-A1 | CRYSTALLINE FORM OF COMPOUND SUPPRESSING PROTEIN KINASE ACTIVITY, AND APPLICATION THEREOF | MAPKAPK5, MAP3K6, MAP3K5 | ALDH1A1 4112/4885TSHR 2309/4885TDP1 2260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.